SIMPLIFY HEALTH CARE ETF(PINK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PINK SIMPLIFY HEALTH CARE ETF

已收盘 09-22 16:00:00 EDT

39.10

+0.16

+0.41%

盘后39.10

+0.000.00%

19:30 EDT

最高39.30	最低38.95	成交量4.83万
今开38.95	昨收38.94	日振幅0.90%
总市值3.64亿	流通市值3.64亿	总股本930.00万
成交额189.34万	换手率0.52%	流通股本930.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PINK","market":"US","secType":"STK","nameCN":"SIMPLIFY HEALTH CARE ETF","latestPrice":39.1014,"timestamp":1790107200000,"preClose":38.94,"halted":0,"volume":48294,"hourTrading":{"tag":"盘后","latestPrice":39.1014,"preClose":39.1014,"latestTime":"19:30 EDT","volume":12,"amount":469.394,"timestamp":1790119802818,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.004144838212634834,"floatShares":9300001,"shares":9300001,"eps":0,"marketStatus":"已收盘","change":0.1614,"latestTime":"09-22 16:00:00 EDT","open":38.95,"high":39.3,"low":38.95,"amount":1893412.439064,"amplitude":0.008988,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1790150400000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":38.94,"sharesOutstanding":7975001,"nav":39.1421,"aum":360975224.01,"dividendRate":0.006353,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.1014,"preClose":39.1014,"latestTime":"19:30 EDT","volume":12,"amount":469.394,"timestamp":1790119802818,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.211791,"impliedVol":0.0906,"impliedVolPercentile":0.4382},"requestUrl":"/m/hq/s/PINK","defaultTab":"news","newsList":[{"id":"2669142648","title":"Viking Therapeutics涨超35%！减肥药传来捷报：给药频率减半仍维持97%减重","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142648","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669142648?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:50","pubTimestamp":1790085009,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Viking Therapeutics周二盘前一度飙升近50%，此前这家生物科技公司宣布，其实验性肥胖症药物VK2735帮助患者在用药频率从每周一次降至每两周一次的情况下，仍维持了大部分减重成果。这一结果有望进一步增强VK2735在快速扩张的减肥药市场中的竞争地位。截至发稿，VKTX股价上涨近23%。今年以来，该股累计下跌约15%。据了解，VK2735是Viking的主要肥胖症候选药物，正在开发注射剂和口服剂两种剂型。","market":"sh","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499522.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LENZ","BK4585","VKTX","NVOX","FHLC","IYH","NVOH","RSPH","PJP","CURE","NVOC","NBDS","PINK","BK4599","OZEM","BK4007","BK4139","FXH","THNR","XLVI","BK4588","MEDI","BK4539","TRUH"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2669633164","title":"减肥药巨头，裁掉了1.3万个岗位","url":"https://stock-news.laohu8.com/highlight/detail?id=2669633164","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669633164?lang=zh_cn&edition=full","pubTime":"2026-09-21 23:20","pubTimestamp":1790004000,"startTime":"0","endTime":"0","summary":"诺和诺德方面表示，通过本轮组织调整，公司节约成本超100亿丹麦克朗，帮助公司重新投向商业化与研发；过往调整累计涉及约1.3万个岗位，目前全球全职员工为6.6万人。2026年上半年，诺和诺德司美格鲁肽产品组合，合计销售额为1121.93亿丹麦克朗，收入已落后竞品礼来的替尔泊肽约102亿美元。在这一阶段，竞争格局将达到顶峰，企业需要在专利到期的司美格鲁肽与下一代肥胖治疗药物之间进行战略定位。本次资本日，诺和诺德公布了2030战略雄心。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-09-21/doc-inisrhfv9159432.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-21/doc-inisrhfv9159432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVOC","NVOX","TRUH","FXH","NVOH","CURE","PINK","THNR","FHLC","PJP","XLVI","MEDI","IYH","NBDS","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669318161","title":"减肥药巨头诺和诺德本轮调整，裁掉了1.3万个岗位","url":"https://stock-news.laohu8.com/highlight/detail?id=2669318161","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669318161?lang=zh_cn&edition=full","pubTime":"2026-09-21 22:08","pubTimestamp":1789999702,"startTime":"0","endTime":"0","summary":"去年9月份宣布要裁员9000人的诺和诺德，于9月21日在伦敦举办的资本市场日上披露了最终减员情况。诺和诺德方面表示，通过本轮组织调整，公司节约成本超100亿（15.35亿美元）丹麦克朗，帮助公司重新投向商业化与研发；过往调整累计涉及约1.3万个岗位，目前全球全职员工为6.6万人。诺和诺德本轮人员优化背后，核心动因是支撑公司七成以上营收的王牌产品司美格鲁肽，正面临增长承压的挑战。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213880315953.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213880315953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["THNR","NVOH","IYH","FXH","FHLC","RSPH","NVOC","NVOX","NBDS","MEDI","XLVI","BGIA","PJP","TRUH","CURE","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669759159","title":"注射明星减肥药或导致失明？礼来和诺和诺德两巨头在美遭患者起诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2669759159","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669759159?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:54","pubTimestamp":1789980888,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XLVI","FHLC","FXH","NBDS","NVOC","THNR","MEDI","PINK","CURE","IYH","RSPH","TRUH","NVOX","PJP","BGIA","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669590351","title":"注射明星减肥药或导致失明？礼来和诺和诺德两巨头在美遭患者起诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2669590351","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669590351?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:53","pubTimestamp":1789980780,"startTime":"0","endTime":"0","summary":"一起美国的诉讼，让GLP-1药物的安全性再次受到行业关注。据外媒报道称，自2025年以来，一律所代表患者在美国新泽西州州法院提起了90多起诉讼，其起诉的对象是明星GLP-1药物司美格鲁肽背后的药企诺和诺德，原因是其在使用降糖版司美格鲁肽之后被诊断为非动脉炎性前部缺血性视神经病变（简称NAION）。上述报道指出，礼来的GLP-1药物替尔泊肽也面临患者针对NAION风险提起的诉讼。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213880057798.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213880057798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PJP","TRUH","IYH","NBDS","BGIA","CURE","MEDI","PINK","FXH","NVOX","THNR","RSPH","NVOH","FHLC","NVOC","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311633","title":"诺和诺德(NVO.US)减肥药拓展低龄市场：STEP Young试验显示司美格鲁肽显著降低儿童肥胖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311633","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665311633?lang=zh_cn&edition=full","pubTime":"2026-09-07 20:15","pubTimestamp":1788783311,"startTime":"0","endTime":"0","summary":"诺和诺德在声明中指出，这项名为STEP Young的试验所纳入的全部受试者，在整个研究期间均接受了生活方式干预，包括限制热量摄入和增加体育锻炼。诺和诺德首席科学官马丁·霍尔斯特·兰格表示：“STEP Young试验的积极结果令人振奋，我们看好司美格鲁肽在帮助罹患肥胖的儿童方面的潜力——这些儿童除生活方式调整外，尚需药物治疗以更有效地管理其肥胖状况。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVOH","RSPH","FHLC","NVOX","IYH","XLVI","NBDS","PINK","NVOC","MEDI","CURE","PJP","FXH","TRUH","BGIA","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311616","title":"诺和诺德(NVO.US)减肥药拓展低龄市场：STEP Young试验显示司美格鲁肽显著降低儿童肥胖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311616","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665311616?lang=zh_cn&edition=full","pubTime":"2026-09-07 20:15","pubTimestamp":1788783311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FXH","TRUH","THNR","NVOX","FHLC","IYH","PJP","NVOC","XLVI","NVOH","MEDI","PINK","RSPH","CURE","BGIA","NBDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882140","title":"Hims & Hers在澳大利亚推出GLP-1减肥药及治疗方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882140","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664882140?lang=zh_cn&edition=full","pubTime":"2026-09-01 10:10","pubTimestamp":1788228656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["FXH","OZEM","TRUH","ELIS","NVOH","CURE","NVOC","JDOC","PINK","MEDI","LLYX","IYH","RSPH","XLVI","NBDS","LLII","THNR","NVOX","PJP","FHLC","ELIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006809","title":"不止步于“减肥药之王” 礼来(LLY.US)拟最高28.8亿美元收购Merida加码自身免疫赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006809","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663006809?lang=zh_cn&edition=full","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来计划以高达28.8亿美元的现金收购Merida Biosciences Inc.，加码自身免疫与过敏疾病领域，以摆脱对减重和糖尿病两大支柱业务的过度依赖——正是这两大市场助其登顶全球药企市值之巅。今年以来，礼来掀起并购狂潮，迄今已宣布的交易总额超过200亿美元。5月，礼来还达成协议，以最高38亿美元收购三家疫苗研发企业。截至发稿，礼来盘前跌0.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NBDS","PINK","TRUH","XLVI","NVOX","FHLC","IYH","MEDI","NVOH","RSPH","NVOC","PJP","CURE","FXH","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006800","title":"不止步于“减肥药之王” 礼来(LLY.US)拟最高28.8亿美元收购Merida加码自身免疫赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663006800?lang=zh_cn&edition=full","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IYH","FHLC","CURE","NBDS","MEDI","PINK","XLVI","NVOX","PJP","NVOC","FXH","NVOH","TRUH","THNR","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662376416","title":"中国减肥药研发公司德睿智药称AI助力研发时间缩短一半","url":"https://stock-news.laohu8.com/highlight/detail?id=2662376416","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662376416?lang=zh_cn&edition=full","pubTime":"2026-08-26 12:03","pubTimestamp":1787717002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["THNR","CURE","FHLC","NVOH","NVOC","CHAT","RSPH","QTOC","PINK","IYH","NBDS","AGIX","MEDI","TRUH","XLVI","NVOX","ARTY","AIPO","FXH","PJP","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660649212","title":"惠誉评级：美国医疗保健网络风险日益增加。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660649212","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660649212?lang=zh_cn&edition=full","pubTime":"2026-08-19 04:43","pubTimestamp":1787085794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MOAT","FXH","HYLG","BK4588","PINK","CURE","RSPH","XLVI","IYH","PTH","JHMH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490484","title":"减肥药营销“战事”升级：从名人“代言”到老板下场，药企在焦虑什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490484","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660490484?lang=zh_cn&edition=full","pubTime":"2026-08-17 18:59","pubTimestamp":1786964340,"startTime":"0","endTime":"0","summary":"2026年以来，国内减肥药赛道的宣发动作愈发密集且新颖。8月16日，一场银屑病慢病管理公益计划在上海启动，活动聚焦于银屑病与肥胖的关系。背后的支持方是信达生物（1801.HK），该公司拥有已经获批的银屑病创新药匹康奇拜单抗，也手握国内明星GLP-1药物玛仕度肽。将其他疾病与肥胖话题关联起来，此次活动侧面打开了减肥药宣传的新思路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173843343562.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173843343562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["RSPH","FHLC","TRUH","PJP","IYH","XLVI","NBDS","MEDI","THNR","FXH","PINK","NVOC","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996687","title":"30周狂卖500万张！GLP-1引爆行情，减肥药口服时代来临","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996687","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996687?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:20","pubTimestamp":1786440001,"startTime":"0","endTime":"0","summary":"据开源证券研报，Wegovy口服片剂上市后处方量快速攀升，30周累计突破500万张，有效扩宽了GLP-1药物可及性边界，驱动减重产业链持续高景气。2026年被业内视作GLP-1减肥药的“口服元年”。产业链全面受益随着海外商业化落地持续超预期，全球GLP-1减重市场规模迎来指数级增长。口服GLP-1药物放量带动规模化生产需求激增，海外药企产能逐步承压，持续将生产环节外包至国内优质代工企业。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260811/32331742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["PJP","PINK","THNR","NBDS","XLVI","JDOC","FHLC","NVOC","GLP","RSPH","FXH","MEDI","BK4144","BK4590","TRUH","IYH","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969925","title":"Hims & Hers Health次季亏损超预期，转向品牌减肥药导致成本上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969925","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969925?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:46","pubTimestamp":1786419965,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MEDI","NBDS","THNR","FXH","CURE","PJP","FHLC","NVOC","TRUH","IYH","PINK","RSPH","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657896386","title":"美国银行每年砸2.5亿美元支持员工使用GLP-1减肥药","url":"https://stock-news.laohu8.com/highlight/detail?id=2657896386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657896386?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:06","pubTimestamp":1786007162,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1280957306.USD","LU0211331839.USD","FHLC","LU0053666078.USD","IE00BBT3K403.USD","LU0648001328.SGD","KBWB","IE00B19Z3B42.SGD","XLF","IYF","IE0001KFT4U8.USD","IYH","CURE","IE00BZ1G4Q59.USD","LU0106831901.USD","THNR","LU0980610538.SGD","BK4588","LU0314106906.USD","GLP","LU1506573853.SGD","LU0130103400.USD","MEDI","FNCL","LLYX","NBDS","BK4590","RSPH","BAC","FTXO","IYG","PINK","ELIS","PJP","ELIL","LLYZ","PGF","TRUH","VFH","XLVI","JDOC","LU1496350171.SGD","TFNS","FXH","LLII","NVOC","UYG","BK4534","LU0170899867.USD","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657674945","title":"安进二季度强劲药品销售，上调预期，将终止早期减肥药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2657674945","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657674945?lang=zh_cn&edition=full","pubTime":"2026-08-05 05:11","pubTimestamp":1785877860,"startTime":"0","endTime":"0","summary":"　　$安进$公司于周二美股收盘后公布财报，第二季度强劲药品销售提振公司利润，因此上调了全年预期，但同时表示将终止一款早期减肥疗法的开发。　　这家生物技术公司周二表示，将停止AMG 513的开发，这是一款目前处于1期研究阶段的潜在减肥疗法。安进称，该研究将完成以跟踪已入组受试者。　　随着AMG 513开发的终止，安进在该领域唯一的候选药物是MariTide，该药目前正在进行针对肥胖、2型糖尿病和慢性体重管理等适应症的3期研究。","market":"us","thumbnail":"https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimezkz1673958.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU0889565916.HKD","LU2089984988.USD","IE0002141913.USD","TBXU","XLVI","PJP","IE0009355771.USD","IBB","BK4566","FHLC","BK4581","BK4139","LU2468319806.SGD","LU2242646821.SGD","LU1023059063.AUD","LU0122379950.USD","BK4533","LU1983299246.USD","LU0868494617.USD","BIB","BBH","IYH","IE00BJT1NW94.SGD","BK4588","BK4599","SG9999001440.SGD","IE00BJJMRZ35.SGD","RSPH","LU0058720904.USD","NVOC","LU0320765992.SGD","LU1571399168.USD","LU1061106388.HKD","IBBQ","LU0289739699.SGD","THNR","PBE","AMGN","LU0109394709.USD","PINK","CURE","FXH","MEDI","BK4534","IE00B2B36J28.USD","TRUH","NBDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652726614","title":"A股减肥药板块低开高走，海正药业涨停，博腾股份涨超4%，翰宇药业、众生药业、皓元医药、恒瑞医药等个股跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2652726614","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652726614?lang=zh_cn&edition=full","pubTime":"2026-07-20 10:04","pubTimestamp":1784513089,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["THNR","CURE","FXH","MEDI","NBDS","IYH","RSPH","FHLC","PJP","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651471109","title":"HCA医疗下调年度营收预期后，医院运营商股价集体下跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651471109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651471109?lang=zh_cn&edition=full","pubTime":"2026-07-14 21:37","pubTimestamp":1784036274,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SG9999014039.USD","LU0878866978.SGD","LU0648001328.SGD","LU0310799852.SGD","LU2355687059.USD","XHS","LU0433182093.SGD","LU1267930490.SGD","LU1084165304.USD","LU0130102774.USD","LU0068578508.USD","LU2244417387.USD","LU0708994859.HKD","LU0128525929.USD","IE00B775SV38.USD","HCA","LU0985489474.SGD","BK4504","BK4585","BK4185","LU1119994496.HKD","LU0310800379.SGD","SG9999014021.USD","LU1150488218.USD","LU0211328371.USD","IE00B3S45H60.SGD","LU0868494617.USD","LU0980610538.SGD","SG9999014005.SGD","PINK","BK4588","LU0882574055.USD","SG9999014013.SGD","IHF","CURE","LU1201861249.SGD","LU1150488135.SGD","LU1267930573.SGD","LU0203347892.USD","LU1489326972.SGD","LU0187121727.USD","LU0029864427.USD","LU0211327993.USD","LU0114720955.EUR","LU0203345920.USD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651112380","title":"“笔帽”专利诉讼背后：减肥药带火百亿注射笔赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2651112380","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651112380?lang=zh_cn&edition=full","pubTime":"2026-07-13 21:23","pubTimestamp":1783948980,"startTime":"0","endTime":"0","summary":"一起“笔帽”专利纠纷，揭开GLP-1注射笔百亿市场的一角。7月10日，银诺医药（2591.HK）通过官方微信公众号发布情况说明，称公司作为被告涉及一起实用新型专利侵权诉讼，原告为苏州嘉树生物医疗科技有限公司（简称“苏州嘉树”），诉讼的核心问题不是银诺医药GLP-1产品依苏帕格鲁肽α注射液本身，而是产品配套使用的预充式注射笔中笔帽是否存在侵权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607133804157469.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607133804157469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["RSPH","CURE","PJP","PINK","FXH","IYH","PATN","MEDI","ITAN","FHLC","NBDS","THNR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0031},{"period":"1month","weight":-0.0316},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1702},{"period":"1year","weight":0.2409},{"period":"ytd","weight":0.0639}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0544},{"period":"6month","weight":0.1776},{"period":"1year","weight":0.1654},{"period":"ytd","weight":0.1343}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.012643},{"month":2,"riseRate":0.6,"avgChangeRate":0.005136},{"month":3,"riseRate":0.6,"avgChangeRate":-0.001509},{"month":4,"riseRate":0.6,"avgChangeRate":-0.008129},{"month":5,"riseRate":0.6,"avgChangeRate":0.008295},{"month":6,"riseRate":0.8,"avgChangeRate":0.032925},{"month":7,"riseRate":0.6,"avgChangeRate":0.011634},{"month":8,"riseRate":0.6,"avgChangeRate":0.002039},{"month":9,"riseRate":0.2,"avgChangeRate":-0.01156},{"month":10,"riseRate":0.5,"avgChangeRate":0.018501},{"month":11,"riseRate":0.8,"avgChangeRate":0.042023},{"month":12,"riseRate":0.4,"avgChangeRate":0.008788}],"exchange":"ARCA","name":"SIMPLIFY HEALTH CARE ETF","nameEN":"SIMPLIFY HEALTH CARE ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SIMPLIFY HEALTH CARE ETF(PINK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SIMPLIFY HEALTH CARE ETF(PINK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SIMPLIFY HEALTH CARE ETF,PINK,SIMPLIFY HEALTH CARE ETF股票,SIMPLIFY HEALTH CARE ETF股票老虎,SIMPLIFY HEALTH CARE ETF股票老虎国际,SIMPLIFY HEALTH CARE ETF行情,SIMPLIFY HEALTH CARE ETF股票行情,SIMPLIFY HEALTH CARE ETF股价,SIMPLIFY HEALTH CARE ETF股市,SIMPLIFY HEALTH CARE ETF股票价格,SIMPLIFY HEALTH CARE ETF股票交易,SIMPLIFY HEALTH CARE ETF股票购买,SIMPLIFY HEALTH CARE ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SIMPLIFY HEALTH CARE ETF(PINK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SIMPLIFY HEALTH CARE ETF(PINK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}